Cargando…
A biomimetic nanoparticle-enabled toxoid vaccine against melittin
BACKGROUND: Melittin, the main active peptide ingredient of bee venom, can cause severe cell membrane lysis due to its robust interaction with negatively charged phospholipids. So far, no effective anti-melittin vaccine has been developed to protect people from undesired melittin intoxication. METHO...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987856/ https://www.ncbi.nlm.nih.gov/pubmed/29910613 http://dx.doi.org/10.2147/IJN.S156346 |
_version_ | 1783329193977708544 |
---|---|
author | Kang, Tianyi Li, Chenyang Du, Ting Wu, Yujiao Yang, Yuping Liu, Xuan Zhang, Qianqian Xu, Xiaoping Gou, Maling |
author_facet | Kang, Tianyi Li, Chenyang Du, Ting Wu, Yujiao Yang, Yuping Liu, Xuan Zhang, Qianqian Xu, Xiaoping Gou, Maling |
author_sort | Kang, Tianyi |
collection | PubMed |
description | BACKGROUND: Melittin, the main active peptide ingredient of bee venom, can cause severe cell membrane lysis due to its robust interaction with negatively charged phospholipids. So far, no effective anti-melittin vaccine has been developed to protect people from undesired melittin intoxication. METHODS: Herein, we prepared a polydiacetylene (PDA) nanoparticle with cell membrane-mimic surface to complex melittin, forming an anti-melittin vaccine (PDA–melittin). RESULTS: PDA nanoparticles could effectively combine with melittin and neutralize its toxicity. PDA–melittin nanocomplex is demonstrated to enhance melittin uptake by DCs and stimulate strong melittin-specific immunity. Mice immunized with PDA–melittin nanocomplex showed higher survival rate after exposion to melittin than untreated mice. CONCLUSION: The PDA–melittin nanocomplex can efficiently and safely generate a specific immunity against melittin to protect body from melittin intoxication, providing a new method with potential clinical application for the treatment of melittin intoxication. |
format | Online Article Text |
id | pubmed-5987856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59878562018-06-15 A biomimetic nanoparticle-enabled toxoid vaccine against melittin Kang, Tianyi Li, Chenyang Du, Ting Wu, Yujiao Yang, Yuping Liu, Xuan Zhang, Qianqian Xu, Xiaoping Gou, Maling Int J Nanomedicine Original Research BACKGROUND: Melittin, the main active peptide ingredient of bee venom, can cause severe cell membrane lysis due to its robust interaction with negatively charged phospholipids. So far, no effective anti-melittin vaccine has been developed to protect people from undesired melittin intoxication. METHODS: Herein, we prepared a polydiacetylene (PDA) nanoparticle with cell membrane-mimic surface to complex melittin, forming an anti-melittin vaccine (PDA–melittin). RESULTS: PDA nanoparticles could effectively combine with melittin and neutralize its toxicity. PDA–melittin nanocomplex is demonstrated to enhance melittin uptake by DCs and stimulate strong melittin-specific immunity. Mice immunized with PDA–melittin nanocomplex showed higher survival rate after exposion to melittin than untreated mice. CONCLUSION: The PDA–melittin nanocomplex can efficiently and safely generate a specific immunity against melittin to protect body from melittin intoxication, providing a new method with potential clinical application for the treatment of melittin intoxication. Dove Medical Press 2018-06-01 /pmc/articles/PMC5987856/ /pubmed/29910613 http://dx.doi.org/10.2147/IJN.S156346 Text en © 2018 Kang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Kang, Tianyi Li, Chenyang Du, Ting Wu, Yujiao Yang, Yuping Liu, Xuan Zhang, Qianqian Xu, Xiaoping Gou, Maling A biomimetic nanoparticle-enabled toxoid vaccine against melittin |
title | A biomimetic nanoparticle-enabled toxoid vaccine against melittin |
title_full | A biomimetic nanoparticle-enabled toxoid vaccine against melittin |
title_fullStr | A biomimetic nanoparticle-enabled toxoid vaccine against melittin |
title_full_unstemmed | A biomimetic nanoparticle-enabled toxoid vaccine against melittin |
title_short | A biomimetic nanoparticle-enabled toxoid vaccine against melittin |
title_sort | biomimetic nanoparticle-enabled toxoid vaccine against melittin |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987856/ https://www.ncbi.nlm.nih.gov/pubmed/29910613 http://dx.doi.org/10.2147/IJN.S156346 |
work_keys_str_mv | AT kangtianyi abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT lichenyang abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT duting abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT wuyujiao abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT yangyuping abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT liuxuan abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT zhangqianqian abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT xuxiaoping abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT goumaling abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT kangtianyi biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT lichenyang biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT duting biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT wuyujiao biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT yangyuping biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT liuxuan biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT zhangqianqian biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT xuxiaoping biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin AT goumaling biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin |